The cumulative loss-of-function mutation frequency of BARD1 was reported to range between 0.12% and 0.49% in other studies analyzing at least 1000 BC patients with multigene panels (screening the whole coding sequence of BARD1) [42,43,45,51,59,61,74]. Here, BARD1 is linked to breast cancer.